|
Dec 6
|
Ocular Therapeutix, Inc.'s (NASDAQ:OCUL) large institutional owners must be happy as stock continues to impress, up 56% over the past week
|
|
Nov 8
|
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q3 2023 Earnings Call Transcript
|
|
Nov 7
|
Ocular Therapeutix™ Provides Third Quarter 2023 Financial Results and Corporate Update
|
|
Sep 6
|
Ocular Therapeutix™ to Present at Three Upcoming Investor Conferences
|
|
Aug 9
|
Ocular Therapeutix™ to Present at the H.C. Wainwright 3rd Annual Ophthalmology Virtual Conference
|
|
Aug 8
|
Q2 2023 Ocular Therapeutix Inc Earnings Call
|
|
Aug 7
|
Ocular Therapeutix (OCUL) Reports Q2 Loss, Tops Revenue Estimates
|
|
Aug 7
|
Ocular Therapeutix™ Provides Second Quarter 2023 Financial Results and Corporate Update
|